← Open Payments lookup

CHELSEA FUJITA-HAFFNER: Open Payments

NPI 1841832847 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,717 in 121 payments from 15 companies in 2025. Trend: 2023 $2,117 · 2024 $1,699 · 2025 $3,717

Food & beverage: $3,019Travel & lodging: $698
CompanyPaymentsAmount
Madrigal Pharmaceuticals46$1,322
Boston Scientific Corporation5$1,007
Janssen Biotech, Inc.12$352
Ardelyx, Inc.12$263
ABBVIE INC.23$262
GENZYME CORPORATION3$88
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$83
Phathom Pharmaceuticals, Inc.4$74
Novo Nordisk Inc3$71
Regeneron Healthcare Solutions, Inc.2$60

Products named: REZDIFFRA, General - Therapies, TREMFYA, IBSRELA, DUPIXENT, CREON, XIFAXAN, VOQUEZNA.

Industry payments across CA — which companies pay providers there.